Intracranial germ cell tumors: a single-institution experience

Abstract

BACKGROUND AND OBJECTIVES: Intracranial germ cell tumors (GCTs) are not a common disease. We reviewed the experience of a single institution to determine the variables that affect treatment outcome. DESIGN AND SETTING: A retrospective review of patients with the diagnosis of intracranial germ cell tumors treated in a single institution (KFSHRC) during the period from March 1985 to December 2007. PATIENTS AND METHODS: Fifty-seven patients with the diagnosis of intracranial GCT were recorded in the KFSHRC Tumor Registry during the period from 1985 to 2007. Seven patients with a pineal region tumor treated as germinomas in the earlier years without a tissue diagnosis were excluded. This retrospective study was restricted to the remaining 50 patients with a tissue or marker diagnosis: 31 germinomas and 19 non-germinomatous germ cell tumors (NGGCTs). RESULTS: The 10-year overall survival (OS), event-free survival (EFS) and relapse-free survival (RFS) were 87%, 88% and 96% for patients with germinoma, with a median follow-up of 4.5 (range 2–17) years, compared with 26%, 29% and 46% for patients with NGGCT with a median follow-up of 3 (range 1.5–13) years. For NGGCT, variables favorably influencing OS were younger age (50 Gy vs ≤ 50 Gy; P=.03) and later year of diagnosis (>1990 vs 50 Gy are important factors that influence the outcome. Second-look surgery and resection of residual/refractory tumors is always recommended.